
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases the cost of such medication exponentially, according to federal investigators.
UnitedHealth Group, who employed the recently deceased CEO Brian Thompson, has been collecting additional revenue by inflating the price of drugs that are medically necessary for the patients they are prescribed to, according to a report from the Federal Trade Commission.